pe
pep-04867 v1 CC-BY-SA-4.0

Blood-pressure-lowering peptide (LVLPGE)

A small natural peptide that blocks the enzyme that raises blood pressure; studied as a possible blood-pressure treatment, still experimental and not an approved drug.

statusbioassayed targetACE length6 aa refs1
angiotensin-converting-enzyme-ace-inhibitors
EARLY ENTRY This candidate is newly indexed — supporting evidence is still being added. Have a paper or data point? Contribute below.
status 2 / 5 · 0 verified on platform
prediction metrics boltz-2 1.0
ipTM0.741
pTM0.618
avg pLDDT90.9
ranking score0.875
STRUCTURE · PEP-04867 × ACE
ranking0.875
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
boltz-2 1.0 · mmCIF ↓ download
sequence6 aa
156
LVLPGE
details expand to inspect
full evidence table2 metrics
metricvaluetool
ipTM 0.7410194277763367 boltz-2
ranking score 0.8750948309898376 boltz-2
structural qualityopenfold3
metricvaluenote
gpde0.918global PDE — lower = better
disorderNaNfraction disordered
3-letter notation
Leu-Val-Leu-Pro-Gly-Glu
recipeboltz-2 1.0
parametervalue
modelboltz-2 1.0
weights
hardwarenvidia_nim_api
mlx version
python
random seed
msa strategynone
diffusion samples1
runtime
predicted bymlx@peptide
predicted at2026-04-24
citationbibtex
peptidemodel (2026). Blood-pressure-lowering peptide (LVLPGE) (pep-04867, v1). PeptideModel. https://peptidemodel.com/card/pep-04867
@peptide{pep04867,
  sequence = {LVLPGE},
  target   = {ace},
  author   = {peptidemodel},
  year     = {2026},
  status   = {bioassayed}
}
references 1 papers
discussion no comments
sign in to comment
peptidemodel.com CC-BY-SA-4.0 research only · not for human use